Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Q2 2025 Earnings Call Transcript August 7, 2025
Phathom Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.79 EPS, expectations were $-0.76.
Operator: Hello, and welcome to the Phathom Pharmaceuticals Second Quarter 2025 Earnings Results Call. [Operator Instructions] Please be advised that today’s call is being recorded. With that, I’d like to turn the call over to Eric Sciorilli, Phathom’s Head of Investor Relations....
